pudafensine   Click here for help

GtoPdb Ligand ID: 13226

Synonyms: IP2015 | IPED-2015 | IPED2015
Compound class: Synthetic organic
Comment: The chemical structure for pudafensine was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a monoamine reuptake inhibitor. Online information indicates that this is Initiator Pharma's clinical candidate IP2015.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 56.79
Molecular weight 303.35
XLogP 1.29
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES COC1CC2=CC=C(C=C2OC1=O)O[C@H]3C[C@]4([H])CC[C@]([H])(C3)N4
Isomeric SMILES [H][C@]12CC[C@]([H])(C[C@H](C1)OC3=CC4=C(CC(OC)C(=O)O4)C=C3)N2
InChI InChI=1S/C17H21NO4/c1-20-16-6-10-2-5-13(9-15(10)22-17(16)19)21-14-7-11-3-4-12(8-14)18-11/h2,5,9,11-12,14,16,18H,3-4,6-8H2,1H3/t11-,12+,14-,16?
InChI Key WPAFIYCKXZOAAG-ABOKDIFFSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
No information available.
Summary of Clinical Use Click here for help
Pudafensine (IP2015) has been advanced as a clinical candidate for organic erectile dysfunction and neuropathic pain.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05728671 Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 Phase 1 Interventional Initiator Pharma
NCT05181852 Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model Phase 1 Interventional Initiator Pharma
NCT04969666 A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction Phase 2 Interventional Initiator Pharma